Pfizer lost 1/3 of its cap after our call in February and is in the middle of the target area. Today we will evaluate the perspectives for the annual closure. Call in February 2023: Follow us on Telegram channel where all newest posts are relayed to automatically: https://t.me/InvestingAngles If you want to receive notifications about […]

Love old charts. Pfizer lost 31% after our call in February, 9 months ago. This one goes to the Track Record. If you are concerned about missing a post or a study on our site, you could follow us on Telegram channel where all newest posts are relayed to automatically: https://t.me/InvestingAngles If you want to […]

Pfizer lost 29% after our call in February and signals no reversal yet. Targets remain the same for now. CANDLES PERSPECTIVE Both the monthly and 2-month frames formed bearish continuation candles. We also remember that the stock closed Q3 in September with a bearish continuation candle. The quarterly price moved through the 50 QMA for […]

Pfizer lost 23% after our call on February 16th and signals a continued southbound move. Targets remain the same, but could be reviewing in the next few months. If you are concerned about missing a post or a study on our site, you could follow us on Telegram channel where all newest posts are relayed […]

Pfizer lost 14.5% after our call on February 16th and, after the quarterly closure, signals more damage ahead. Targets remain the same. Join us on Telegram: https://t.me/InvestingAngles CANDLES PERSPECTIVE After making a Tower Top in Q1, the stock completed another Tower Top on the 6M frame and further elevated already very bearish odds. The monthly […]